Status:
COMPLETED
Bone Loss in Women With Anorexia Nervosa
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Center for Research Resources (NCRR)
Conditions:
Anorexia Nervosa
Eligibility:
FEMALE
18-45 years
Phase:
PHASE2
PHASE3
Brief Summary
Women with Anorexia Nervosa have been found to have low bone density. The study will determine whether administration of low doses of a natural hormone, testosterone and/or risedronate, a medication t...
Detailed Description
II. SPECIFIC AIMS Severe osteopenia is a prevalent complication of anorexia nervosa (AN), affecting over half of all women with this disease. Loss of 25-50% of total bone mass occurs frequently and i...
Eligibility Criteria
Inclusion
- Anorexia Nervosa,
- Over 18,
- Female,
- Decreased bone density
Exclusion
- Medications to increase bone density
Key Trial Info
Start Date :
June 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2008
Estimated Enrollment :
77 Patients enrolled
Trial Details
Trial ID
NCT00089843
Start Date
June 1 2003
End Date
April 1 2008
Last Update
September 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114